Zobrazeno 1 - 10
of 596
pro vyhledávání: '"PIERRE D. DELMAS"'
Autor:
RENE RIZZOLI, NANSA BURLET, DAVID CAHALL, PIERRE D. DELMAS, ERIK F. ERIKSEN, DIETER FELSENBERG, JOHN GRBIC, MATS JONTELL, REGINA LANDESBERG, ANDREA LASLOP, PETER MATTON, SOCRATES PAPAPOULOS, ORHAN SEZER, MICHAEL SPRAFKA, JEAN-YVES REGINSTER
Publikováno v:
Остеопороз и остеопатии, Vol 10, Iss 2, Pp 19-21 (2007)
Externí odkaz:
https://doaj.org/article/d819336675f54f91859955db5079b64e
Publikováno v:
Robot Localization and Map Building
GNSS (Global Navigation Satellite System) system is the most famous system to realize localization of mobile robots. It is able to provide a global position everywhere in the world. Moreover, as it provides a global position, it is not necessary to p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17a39920b7c6129dc4e38978183e584c
http://www.intechopen.com/articles/show/title/reliable-localization-systems-including-gnss-bias-correction
http://www.intechopen.com/articles/show/title/reliable-localization-systems-including-gnss-bias-correction
Autor:
Ego Seeman, Roland Chapurlat, Elisabeth Sornay-Rendu, Eric Lespessailles, Pierre D. Delmas, Roger Zebaze, Danny Liew, Minh Bui
Publikováno v:
Journal of Bone and Mineral Research
Journal of Bone and Mineral Research, American Society for Bone and Mineral Research, 2020, 35 (5), pp.833-844. ⟨10.1002/jbmr.3924⟩
Journal of Bone and Mineral Research, American Society for Bone and Mineral Research, 2020, 35 (5), pp.833-844. ⟨10.1002/jbmr.3924⟩
More than 70% of women sustaining fractures have osteopenia or “normal” bone mineral density (BMD). These women remain undetected using the BMD threshold of −2.5 SD for osteoporosis. As microstructural deterioration increases bone fragility dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d2060a13ee12f5d3aef479aa2373ae6
https://hal.archives-ouvertes.fr/hal-03256850
https://hal.archives-ouvertes.fr/hal-03256850
Publikováno v:
Osteoporosis International. 24:2345-2352
This observational study showed that after 2 years, both risedronate and alendronate lowered the risk of hip and nonvertebral fractures compared with patients filling in a single bisphosphonate prescription.Post hoc analyses of the placebo-controlled
UNLABELLED: Published meta-analyses have investigated the relationship between changes in BMD and fracture risk reduction observed with antiresorptive agents, with inconsistent results. Many factors may affect the outcome of such analyses. Our work e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70109aa3a7538f1fbc93f2abeaa00895
https://ora.ox.ac.uk/objects/uuid:e12d7ace-f696-4663-9d1b-5b10d539afa5
https://ora.ox.ac.uk/objects/uuid:e12d7ace-f696-4663-9d1b-5b10d539afa5
Autor:
Stuart L. Silverman, Johannes Pfeilschifter, Cyrus Cooper, Frederick A. Anderson, Pierre D. Delmas, P. N. Sambrook, J C Netelenbos, S. Adami, Susan L. Greenspan, C Roux, Adolfo Diez-Perez, Juliet E. Compston, F H Hooven, Nelson B. Watts, Robert Lindsay, Ethel S. Siris, Kenneth G. Saag, Andrea Z. LaCroix, Stephen H. Gehlbach, Steven Boonen, Jonathan D. Adachi
Publikováno v:
Osteoporosis International
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, vol 20, iss 7
Osteoporosis International, 20(7), 1107-1116. Springer London
Hooven, F H, Adachi, J D, Adami, S, Boonen, S, Compston, J, Cooper, C, Delmas, P D, Diez Perez, A, Gehlbach, S, Greenspan, S L, Lacroix, A, Lindsay, R, Netelenbos, J C, Pfeilschifter, J, Roux, C, Saag, KG, Sambrook, P N, Silverman, S, Siris, E, Watts, N B & Anderson, F A 2009, ' The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design ', Osteoporosis International, vol. 20, no. 7, pp. 1107-1116 . https://doi.org/10.1007/s00198-009-0958-2
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, vol 20, iss 7
Osteoporosis International, 20(7), 1107-1116. Springer London
Hooven, F H, Adachi, J D, Adami, S, Boonen, S, Compston, J, Cooper, C, Delmas, P D, Diez Perez, A, Gehlbach, S, Greenspan, S L, Lacroix, A, Lindsay, R, Netelenbos, J C, Pfeilschifter, J, Roux, C, Saag, KG, Sambrook, P N, Silverman, S, Siris, E, Watts, N B & Anderson, F A 2009, ' The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design ', Osteoporosis International, vol. 20, no. 7, pp. 1107-1116 . https://doi.org/10.1007/s00198-009-0958-2
SUMMARY: The Global Longitudinal study of Osteoporosis in Women (GLOW) is a prospective cohort study involving 723 physicians and 60,393 women subjects >or=55 years. The data will provide insights into the management of fracture risk in older women o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2964c329763a45356a69c88cd808257
https://ora.ox.ac.uk/objects/uuid:1fac6eb9-964d-43dd-9000-6870b50442b5
https://ora.ox.ac.uk/objects/uuid:1fac6eb9-964d-43dd-9000-6870b50442b5
Autor:
Nansa Burlet, Jean-Yves Reginster, Cyrus Cooper, René Rizzoli, Pierre D. Delmas, Olivier Bruyère
Publikováno v:
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders, Vol 9, Iss 1, p 165 (2008)
BMC Musculoskeletal Disorders, Vol. 9 (2008) P. 165
BMC Musculoskeletal Disorders, Vol 9, Iss 1, p 165 (2008)
BMC Musculoskeletal Disorders, Vol. 9 (2008) P. 165
Background: Symptomatic slow-acting drugs (SYSADOA) have been largely studied over the last decade. The objective of this study is to prepare a document providing recommendations for the use of SYSADOA in osteoarthritis (OA). Methods: The following i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a55c5e808e610aa51aa8d24c16fa71b
https://ora.ox.ac.uk/objects/uuid:73db719c-ef8e-4a45-a7fb-8fae3b21fb86
https://ora.ox.ac.uk/objects/uuid:73db719c-ef8e-4a45-a7fb-8fae3b21fb86
Autor:
S. Adami, George A. Wells, Paul D. Miller, Ethel S. Siris, Jean-Yves Reginster, Jonathan D. Adachi, Cyrus Cooper, Ann Cranney, E. Yetisir, Socrates E. Papapoulos, Pierre D. Delmas, S. Silverman, Philip N. Sambrook
UNLABELLED: This analysis was conducted to assess the effect of high versus lower doses of ibandronate on nonvertebral fractures. The results were adjusted for clinical fracture, age, and bone density. The treatment effect was dose-dependent. Higher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd814f3e2572ace49f326ffb34ecf619
https://ora.ox.ac.uk/objects/uuid:60cf463e-d9b9-47e6-9e2a-371a95827479
https://ora.ox.ac.uk/objects/uuid:60cf463e-d9b9-47e6-9e2a-371a95827479
Autor:
Ellen Matzkin, Jose R. Zanchetta, Pierre D. Delmas, John F. Beary, Claude-Laurent Benhamou, Christian Roux, Steven Boonen, Rachelle Eusebio, Z. Man, Artur J. Racewicz, Michael R. McClung, David Ernest Burgio
Publikováno v:
Osteoporosis International
Summary: This study showed that risedronate 150-mg once a month provides similar efficacy and safety at 2 years compared with risedronate 5-mg daily for the treatment of postmenopausal osteoporosis. This adds to the range of risedronate dosing option
Autor:
Pierre D. Delmas, M.C. de Vernejoul, Roland Chapurlat, Thierry Thomas, Michel Laroche, S. Rouanet
Publikováno v:
Osteoporosis International. 24:311-320
We have examined the effect of oral monthly ibandronate on distal radius and tibia microarchitecture with high-resolution peripheral quantitative tomography compared with placebo, in women with osteopenia, and found that ibandronate did not significa